Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion

Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Tags: TCT MEETINGS BEST ABSTRACTS Source Type: research